Type 2 Diabetes Mellitus: Magnitude of the Problem and Failure to Achieve Glycemic Control

Endocrinology and Metabolism Clinics of North America

Volumn 35, Issue SUPPL. 1, 2006, Pages 3-5

  Zinman, Bernard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INCRETIN; INSULIN;

ADIPOSE TISSUE; ARTICLE; BODY MASS; DISEASE COURSE; EPIDEMIC; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC REGULATION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; DISEASE OUTBREAKS; HUMANS; HYPERGLYCEMIA; TREATMENT FAILURE;

EID: 34147143949     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(07)70003-8     Document Type: Article

References (14)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Hogan P., Dall T., Nikolov P., and American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917-932
3. Resnick H., Harris M., Brock D., and Harris T. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 23 (2000) 176-180
4. Harris M., Flegal K., Cowy C., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21 (1998) 518-524
5. Colditz G., Willett W., Rotnitzky A., and Manson J. Weight gain as a risk factor for clinical diabetes melliltus in women. Ann Intern Med 122 (1995) 481-486
6. Young L., and Nestle M. The contribution of expanding portion sizes to the US obesity epidemic. Am J Public Health 92 (2002) 246-249
7. Banerji M., Lebowitz J., Chaiken R., Gordon D., Kral J., and Lebovitz H. Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am J Physiol 273 (1997) E425-E432
8. The Diabetes Control and Complications Trial Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
9. UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
10. Stratton I., Adler A., Neil H., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 321L (2000) 405-412
11. Saydah S., Fradkin J., and Cowie C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 (2004) 335-342
12. Shorr R., Franse L., Resnick H., Di Bari M., Johnson K., and Pahor M. Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Geriatr Soc 48 (2000) 264-267
13. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998) 854-865
14. Viberti G., Kahn S., Greene D., et al. A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes. Diabetes Care 25 (2002) 1737-1743